U.S. flag An official website of the United States government
  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Oncologic Drugs Advisory Committee
  6. Oncologic Drugs Advisory Committee Roster
  1. Oncologic Drugs Advisory Committee

Oncologic Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info

Current Number of Vacancies = 3
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Philip C. Hoffman, MD
Expertise: Medical Oncology
Term: 4/25/2017 – 6/30/2021
Professor of Medicine
The University of Chicago
Section of Hematology/Oncology
Department of Medicine
5841 S. Maryland Avenue, MC 2115
Chicago, Illinois 60637

Designated Federal Officer
She-Chia S. Chen, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8533
E-mail: ODAC@fda.hhs.gov

Jaffer A. Ajani, MD
Expertise: Medical Oncology
Term: 7/1/2019 – 6/30/2023
Professor, Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine
Professor, Department of Epidemiology, Division
of Office of the Vice President, Cancer Prevention and Population Sciences
University of Texas MD Anderson Cancer Center
1400 Holcombe Blvd., FC10.3022
Houston, Texas 77030

Ranjana H. Advani, MD
Expertise: Lymphoma
Term: 12/8/2020 – 6/30/2024
Physician Leader, the Lymphoma Clinical Care Program
Saul A. Rosenberg Professor of Lymphoma
Stanford University Medical Center
875 Blake Wilbur Drive, CC-2338 (MC: 6556)
Stanford, California 94305

**Jonathan D. Cheng, MD
Expertise: Medical Oncology
Term: 11/1/2019 – 10/31/2023
Senior Vice President
Head of Oncology Development
Global Drug Development
Bristol-Myers Squibb
3401 Princeton Pike
Lawrenceville, New Jersey 08648

Massimo Cristofanilli, MD, FACP
Expertise: Medical Oncology
Term: 9/27/2018 – 6/30/2022
Associate Director of Translational Research and Precision Medicine
Robert H. Lurie Comprehensive Cancer Center
710 North Fairbanks Court, Suite 8-250A
Chicago, Illinois 60611

Jorge A. Garcia, MD
Expertise: Medical Oncology
Term: 7/1/2019 – 6/30/2023
Chair, Division of Solid Tumor Oncology
George and Edith Richman Distinguished Scientist Chair
Director, GU Oncology Program
University Hospitals Seidman Cancer Center
Case Comprehensive Cancer Center
Case Western Reserve University
11100 Euclid Avenue, Lakeside Suite 1200
Cleveland, Ohio 44106

Susan Halabi, PhD
Expertise: Biostatistics
Term: 7/1/2017 – 6/30/2021
Professor of Biostatistics and Bioinformatics
Duke University Medical Center
2424 Erwin Road, Suite 11088
Durham, North Carolina 27705

Christopher H. Lieu, MD
Expertise: Medical and Gastrointestinal Oncology
Term: 12/8/2020 – 6/30/2024
Associate Professor of Medicine and Associate Director, Clinical Research
Director, Gastrointestinal Medical Oncology Program
University of Colorado
MS 8117, 12801 E. 17th Avenue, Rm. 8126
Aurora, Colorado 80045

*David E. Mitchell
Expertise: Consumer Representative
Term: 10/22/2019 – 6/30/2024
Founder, Patients for Affordable Drugs
Bethesda, Maryland 20814

Alberto S. Pappo, MD
Expertise: Pediatric Oncology
Term: 6/4/2015 – 6/30/2022
Member and Head, Division of Solid Malignancies
St Jude Children’s Research Hospital
Professor of Pediatrics
University of Tennessee Health Science Center
Memphis, Tennessee 38105

Anthony D. Sung, MD
Expertise: Hematology
Term: 7/1/2019 – 6/30/2023
Assistant Professor of Medicine
Duke University School of Medicine
Duke Adult Blood and Marrow Transplant Clinic
2400 Pratt Street, Suite 9000, Room 9053
Durham, North Carolina 27705

* Consumer Representative
** Industry Representative, non voting

Back to Top